Patents Assigned to CANVAX BIOTECH SL
  • Patent number: 9347942
    Abstract: The present invention relates to a novel cell based sensor useful for drug discovery that comprises a cell line with professional regulated exocytosis of secretory granules transfected with a protease as a reporter polypeptide stored in the regulated secretory granules of the cell line with professional regulated exocytosis and having either an endogenous or a heterologous molecule as a modulator of regulated secretory granules exocytosis, such said granule stored protease reporter having at least: a high resistance to conditions already present inside the granules such as low pH and proteolysis by other proteases; enzymatic activity after exocytosis; a highly specific cleavage sequence; a very low level of secretion under unstimulated or basal conditions; and a high signal to background activity in a media compatible with cell culture viability and granule exocytosis for a high throughput robust and sensitive detection.
    Type: Grant
    Filed: July 28, 2010
    Date of Patent: May 24, 2016
    Assignee: CANVAX BIOTECH SL
    Inventors: Elier Paz-Rojas, Maria de Gracia Montero-Peñalvo, Veronica Inmaculada Luna-Guerrero, Fe Isabel Garcia Maceira, Jose Andres Morales-Martínez, Tania Garcia Maceira, Ana Belén Aragón-Gómez, Ana Quesada-Molina, Aurora Maria Marquez-Morales
  • Publication number: 20130203078
    Abstract: The present invention relates to a novel cell based sensor useful for drug discovery that comprises a cell line with professional regulated exocytosis of secretory granules transfected with a protease as a reporter polypeptide stored in the regulated secretory granules of the cell line with professional regulated exocytosis and having either an endogenous or a heterologous molecule as a modulator of regulated secretory granules exocytosis, such said granule stored protease reporter having at least: a high resistance to conditions already present inside the granules such as low pH and proteolysis by other proteases; enzymatic activity after exocytosis; a highly specific cleavage sequence; a very low level of secretion under unstimulated or basal conditions; and a high signal to background activity in a media compatible with cell culture viability and granule exocytosis for a high throughput robust and sensitive detection.
    Type: Application
    Filed: July 28, 2010
    Publication date: August 8, 2013
    Applicant: CANVAX BIOTECH SL
    Inventors: Elier Paz-Rojas, Maria de Gracia Montero-Peñalvo, Veronica Inmaculada Luna-Guerrero, Fe Isabel Garcia Maceira, Jose Andres Morales-Martínez, Tania Garcia Maceira, Ana Belén Aragón-Gómez, Ana Quesada-Molina